Expert Insights on Cancer Care Leadership With Professor Timothy Eberlein - Bioengineer.org
Expert Insights on Cancer Care Leadership With Professor Timothy Eberlein Bioengineer.org
Expert Insights on Cancer Care Leadership With Professor Timothy Eberlein Bioengineer.org
AbbVie’s blood cancer therapy meets late-stage trial goals WSAU
AbbVie’s blood cancer therapy meets late-stage trial goals WTVB
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond Oncodaily
В Баку прошла конференция, посвященная диагностике и лечению рака крови Media.az
Рак – не приговор: врач-онколог Игорь Соловьев о скрининге, лечении и главных мифах XXI века РИА Карачаево-Черкесия
GenBio Inc. Introduces ProlifR™ as Development Identity for Emerging Oncology Research Program EIN News
GenBio Inc. Introduces ProlifR™ as Development Identity for Emerging Oncology Research Program EIN Presswire
Oncology Drugs Fast Tracked by the FDA in August 2026 Oncology News Central
В теле человека обнаружен новый орган! Он стал надеждой в борьбе с раком Haberler
Molecular Glues – A new era of precision cancer treatment The Times of India
OpenEvidence deepens oncology push to enhance specialized AI agent, launches new AI model family Fierce Healthcare
Non-invasive urine test identifies 9 in 10 bladder cancers Oncology Central
OSA Linked to Higher Risk for Heart Failure in Cancer Medscape
Targeting CDK2 Could Boost Immunotherapy Response in Patients with a Wide Range of Cancers, According to Dana-Farber Science | Newswise Newswise